📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Identification and optimization of a novel series of selective PIP5K inhibitors. (2022)

First Author: Andrews DM

Attributed to: The role of Nuclear phosphoinositides in epigenetic signalling funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.bmc.2021.116557

PubMed Identifier: 34922306

Publication URI: http://europepmc.org/abstract/MED/34922306

Type: Journal Article/Review

Volume: 54

Parent Publication: Bioorganic & medicinal chemistry

ISSN: 0968-0896